1 |
Zhang Q, Pan J, An F, Nie H, Zhan Q. Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma. Bioengineered 2021;12:8147-56. [PMID: 34615436 DOI: 10.1080/21655979.2021.1987131] [Reference Citation Analysis]
|
2 |
Zhang F, Guo S, Zhong W, Huang K, Liu Y. Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:672416. [PMID: 34676244 DOI: 10.3389/fmolb.2021.672416] [Reference Citation Analysis]
|
3 |
Alam W, Ullah H, Santarcangelo C, Di Minno A, Khan H, Daglia M, Arciola CR. Micronutrient Food Supplements in Patients with Gastro-Intestinal and Hepatic Cancers. Int J Mol Sci 2021;22:8014. [PMID: 34360782 DOI: 10.3390/ijms22158014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Venturelli S, Leischner C, Helling T, Renner O, Burkard M, Marongiu L. Minerals and Cancer: Overview of the Possible Diagnostic Value. Cancers (Basel) 2022;14:1256. [PMID: 35267564 DOI: 10.3390/cancers14051256] [Reference Citation Analysis]
|
5 |
Li S, Huang J, Yang F, Zeng H, Tong Y, Li K. High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma. Sci Rep 2021;11:11078. [PMID: 34040099 DOI: 10.1038/s41598-021-90507-w] [Reference Citation Analysis]
|
6 |
Escobedo-Monge MF, Barrado E, Parodi-Román J, Escobedo-Monge MA, Torres-Hinojal MC, Marugán-Miguelsanz JM. Copper and Copper/Zn Ratio in a Series of Children with Chronic Diseases: A Cross-Sectional Study. Nutrients 2021;13:3578. [PMID: 34684579 DOI: 10.3390/nu13103578] [Reference Citation Analysis]
|